2018年全國藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應監(jian)測網絡收到新(xin)的(de)和嚴(yan)重藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應/事(shi)件(jian)(jian)報(bao)(bao)(bao)(bao)告49.5萬(wan)份；新(xin)的(de)和嚴(yan)重藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應/事(shi)件(jian)(jian)報(bao)(bao)(bao)(bao)告占同期報(bao)(bao)(bao)(bao)告總數(shu)的(de)33.1%。新(xin)的(de)和嚴(yan)重藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應/事(shi)件(jian)(jian)報(bao)(bao)(bao)(bao)告比例持續增加(jia)，顯(xian)示(shi)我國藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應報(bao)(bao)(bao)(bao)告可利用性持續增加(jia)。2018年藥(yao)(yao)品(pin)(pin)不(bu)(bu)良(liang)反(fan)應/事(shi)件(jian)(jian)報(bao)(bao)(bao)(bao)告中，男(nan)女患(huan)(huan)者比為0.86:1，女性略多(duo)于(yu)男(nan)性。14歲(sui)以(yi)下兒童(tong)患(huan)(huan)者的(de)報(bao)(bao)(bao)(bao)告占9.8%；65歲(sui)以(yi)上(shang)老年患(huan)(huan)者的(de)報(bao)(bao)(bao)(bao)告占27.7%，因(yin)此國家藥(yao)(yao)品(pin)(pin)監(jian)督(du)管理局整(zheng)理2019年最新(xin)兒童(tong)禁藥(yao)(yao)名(ming)單。

2019年兒(er)童(tong)(tong)用(yong)(yong)藥(yao)黑名單中分(fen)為感冒藥(yao)、心腦血管(guan)藥(yao)、腸胃道疾(ji)病(bing)用(yong)(yong)藥(yao)、跌打損傷/骨科用(yong)(yong)藥(yao)、中藥(yao)注射劑等(deng)類(lei)型(xing)藥(yao)物。我國3500多(duo)種(zhong)藥(yao)品制劑中，兒(er)童(tong)(tong)專用(yong)(yong)劑型(xing)僅1.7%，這說明(ming)我國專為兒(er)童(tong)(tong)生產藥(yao)品的企業(ye)少之又少，很多(duo)成人用(yong)(yong)藥(yao)兒(er)童(tong)(tong)不能(neng)服(fu)用(yong)(yong)，因此(ci)整(zheng)理出了相(xiang)關2019年兒(er)童(tong)(tong)禁用(yong)(yong)藥(yao)物。